New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 16, 2013
10:04 EDTALOG, HRL, PNR, EVGN, CTAS, CMI, PVH, NVGS, IPXL, SAFMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Analogic (ALOG) initiated with a Buy at Brean Capital...Impax (IPXL) coverage resumed with a Buy at Goldman...Navigator Holdings (NVGS) initiated with a Buy at Jefferies...Navigator Holdings (NVGS) initiated with an Overweight at Evercore...PVH Corp. (PVH) initiated with a Buy at UBS...Cummins (CMI) initiated with a Buy at BofA/Merrill...Cintas (CTAS) initiated with a Neutral at Credit Suisse…Evogene (EVGN) initiated with an Outperform at Oppenheimer...Evogene initiated with a Neutral at Piper Jaffray...Evogene initiated with an Outperform at Credit Suisse…Avianca (AVH) initiated with a Buy at BofA/Merrill…Avianca initiated with an Overweight at JPMorgan...Avianca initiated with a Buy at Deutsche Bank...Pentair (PNR) initiated with a Buy at Nomura...Hormel Foods (HRL) coverage resumed with a Neutral at Goldman...Sanderson Farms (SAFM) coverage resumed with a Buy at Goldman.
News For ALOG;IPXL;NVGS;PVH;CMI;CTAS;EVGN;PNR;HRL;SAFM From The Last 14 Days
Check below for free stories on ALOG;IPXL;NVGS;PVH;CMI;CTAS;EVGN;PNR;HRL;SAFM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2014
10:00 EDTIPXLOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A10 Networks (ATEN) initiated with a Buy at BofA/Merrill... Actavis (ACT) initiated with a Buy at Sterne Agee... Allergan (AGN) initiated with a Buy at Sterne Agee... Autohome (ATHM) initiated with a Neutral at Credit Suisse... BitAuto (BITA) initiated with an Outperform at Credit Suisse... Centene (CNC) initiated with a Neutral at UBS... Endo International (ENDP) initiated with a Buy at Sterne Agee... FS Investment (FSIC) initiated with an Overweight at Evercore... Hertz (HTZ) initiated with a Buy at Gabelli... Hilton (HLT) initiated with a Hold at Jefferies... Hospira (HSP) initiated with a Neutral at Sterne Agee... ImmunoGen (IMGN) initiated with a Buy at Canaccord... Impax (IPXL) initiated with a Neutral at Sterne Agee... Imperva (IMPV) assumed with a Neutral at Wedbush... Ingredion (INGR) initiated with an Outperform at Credit Suisse... Laredo Petroleum (LPI) initiated with an Outperform at RW Baird... Lpath (LPTN) initiated with a Buy at Canaccord... MediWound (MDWD) initiated with an Outperform at Oppenheimer... Medivation (MDVN) initiated with a Hold at Canaccord... NPS Pharmaceuticals (NPSP) assumed with a Buy at Canaccord... Nimble Storage (NMBL) initiated with a Market Perform at Raymond James... Regeneron (REGN) initiated with a Buy at Canaccord... Salix (SLXP) initiated with a Buy at Sterne Agee... Sibanye Gold (SBGL) initiated with an Outperform at Imperial Capital... Teva (TEVA) initiated with a Neutral at Sterne Agee... Wipro (WIT) assumed with a Hold at Jefferies.
09:15 EDTIPXLImpax launches generic Renvela for kidney disease licensed from Sanofi
Impax Laboratories (IPXL) is commencing shipment of authorized generic Renvela 800 mg tablets, through Global Pharmaceuticals, Impax's generics division. Renvela is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis. Under the terms of a settlement agreement, Sanofi (SNY) company Genzyme agreed to grant Impax a license to sell an allotment of a specified number of bottles of an authorized generic version of Renvela tablets commencing on April 16. Impax continues to pursue approval of its pending Abbreviated New Drug Application for generic Renvela with the FDA.
07:04 EDTIPXLImpax initiated with a Neutral at Sterne Agee
Subscribe for More Information
April 14, 2014
10:55 EDTPVHPVH Corp. management to meet with Piper Jaffray
Meetings to be held in California April 21-22 hosted by Piper Jaffray.
April 11, 2014
07:16 EDTIPXLImpax resubmits new drug application to FDA for Rytary
Subscribe for More Information
April 10, 2014
10:47 EDTIPXL High option volume stocks: KOG PIP IPXL ADP EWH
Subscribe for More Information
April 9, 2014
17:03 EDTALOGAnalogic signs distribution agreement for prostate biopsy solution in Europe
Analogic has entered into a distribution agreement with D&K Technologies, developer of the BioJet Solution, a 3D MRI transrectal ultrasound fusion technology. Analogic will distribute the BioJet system for use with its BK Flex Focus ultrasound systems, for assistance during targeted prostate biopsies, in Austria, Belgium, Denmark, Germany, Great Britain, Luxemburg, North America, Sweden Switzerland, and The Netherlands. Analogic's European launch of this technology will take place in Sweden, April 11-15.
12:07 EDTSAFM, HRLU.S. red meat, poultry production forecast lowered
Subscribe for More Information
10:17 EDTALOGAnalogic announces FDA clearance for handheld Sonic Window ultrasound system
Subscribe for More Information
April 8, 2014
16:32 EDTPVHPVH Corp. announces minority investment in Karl Lagerfeld, terms not disclosed
Subscribe for More Information
April 3, 2014
17:05 EDTCMIMarch Class 8 truck orders in-line with estimates at 27,400, says Wells Fargo
Subscribe for More Information
15:54 EDTCMIMarch Class 8 orders units reported at 27,400 units
Subscribe for More Information
April 2, 2014
11:26 EDTCTASUniFirst tumbles after results, guidance trail expectations
Shares of UniFirst (UNF), a provider of workplace uniforms and protective work wear clothing, are falling after the company's second quarter results and fiscal 2014 guidance trailed analysts' consensus estimates. WHAT'S NEW: This morning, UniFirst reported Q2 adjusted earnings per share of $1.27 and revenue of $344M, compared to expectations of $1.39 and $347.49M, respectively. The company forecast FY14 EPS of $5.60-$5.75, trailing the consensus of $5.91, while FY14 revenue was seen at $1.372B-$1.385B, compared to consensus of $1.38B. On January 8, the company had guided FY14 EPS at the high end of the $5.60-$5.85 range and FY14 revenue at the high end of the $1.372B-$1.385B range. WHAT'S NOTABLE: UniFirst CEO Ronald Croatti said, "Our revised outlook for the remainder of the year reflects lower expectations for our Specialty Garments and First Aid segments as well as an assumption that the recent decline in the value of the Canadian dollar and higher energy prices will continue to influence our results. As a reminder, fiscal 2014 will be a 52 week year for the company compared to fiscal 2013, which was a 53 week year. The negative comparison of one less week of operations will have the impact of reducing our year over year revenues by approximately 2.0% and our fourth quarter revenues by approximately 7.1%." PRICE ACTION: In late morning trading, UniFirst tumbled $10.32, or about 9.2%, to $102.39 on nearly twice its average daily trading volume. Including today's slide, the stock is up about 12% over the past twelve months. OTHERS TO WATCH: Other companies providing workforce uniforms include ARAMARK (ARMK) and Cintas (CTAS).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use